Physician
Lydia O. Njamfa, Md.Pa
Lydia O. Njamfa, Md.Pa was paid $162K by Medicaid between Feb 2018 and Aug 2021, across 28 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 17% of everything it billed.
33Billing provider infoLYDIA O. NJAMFA, MD.PA
RICHARDSON, TX 75080
RICHARDSON, TX 75080
33aNPI1922010479assigned 08/13/2006
33bProvider typeFamily Medicine Physician
28Total paid$162K
24GClaims8,238
24DCodes billed28
24AFirst – last monthFeb 2018 – Aug 2021
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#336 of 1,204
Median peer was paid$31K
This provider vs. median5.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48 | $2K | |
| 2019 | 102 | $2K | |
| 2020 | 1,530 | $30K | |
| 2021 | 6,558 | $127K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 572 | 513 | $27K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 998 | 765 | $26K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 14% | 206 | 154 | $22K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10% | 333 | 293 | $16K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.4% | 300 | 215 | $12K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.7% | 258 | 191 | $11K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.2% | 298 | 199 | $10K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.1% | 1,226 | 387 | $7K |
| 99429 | 2.7% | 248 | 170 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.6% | 289 | 203 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.5% | 342 | 290 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 243 | 111 | $3K |
16 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.8% | 581 | $3K |
| 97804 | 1.8% | 774 | $3K | |
| 99000 | 1.8% | 308 | $3K | |
| 90461 | 1.4% | 407 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 149 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 30 | $482.39 |
| 96160 | <1% | 287 | $354.00 | |
| 81003 | <1% | 130 | $262.05 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 24 | $250.61 |
| 99050 | <1% | 20 | $144.60 | |
| 90734 | <1% | 47 | $10.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 20 | $6.36 |
| 90670 | <1% | 39 | $5.35 | |
| 90633 | <1% | 21 | $2.00 | |
| 90658 | <1% | 72 | $2.00 | |
| 90647 | <1% | 16 | $0.70 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNJAMFA, LYDIA (MEDICAL DIRECTOR)